InQL vs ImmuniWeb® Neuron: 2026 Comparison
InQL is a free dynamic application security testing tool. ImmuniWeb® Neuron is a commercial dynamic application security testing tool by ImmuniWeb. Compare features, ratings, integrations, and community reviews side by side to find the best dynamic application security testing fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
GraphQL API teams embedded in Burp Suite workflows should adopt InQL for its native introspection enumeration and mutation testing capabilities; it catches schema poisoning and input validation gaps that standard web proxies miss entirely. The tool is free and maintains 1,671 GitHub stars, reflecting active community contribution to its attack patterns. Skip this if your GraphQL APIs sit behind strict WAF rules or if you need post-exploitation forensics; InQL excels at discovery and fuzzing but doesn't track API behavior anomalies.
Developers and security teams in SMB to mid-market organizations need fast, low-noise vulnerability scanning without the false-positive tax that kills adoption, and ImmuniWeb® Neuron's money-back zero false-positive SLA actually enforces accountability where competitors just claim accuracy. The AI-enhanced crawling and fuzzing catch OWASP Top 10 and API vulnerabilities across AWS, Azure, and GCP with risk-based scoring tied to working exploits, reducing the triage load your team actually faces. Skip this if you need integrated SAST or supply chain scanning; Neuron is narrowly focused on dynamic testing, which is exactly why it doesn't bloat your pipeline with unrelated findings.
